Exclusive: Spot Bio launches with $40M to study mRNA therapy for muscular dystrophy

Jun 17

Written By Andrew Lee

Read the article

Andrew Lee

Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD